Abera Bioscience AB (NGM:ABERA)
Sweden flag Sweden · Delayed Price · Currency is SEK
8.52
+0.52 (6.50%)
At close: Jun 15, 2026

Abera Bioscience AB Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
26.0423.496.093.3215.4311.95
Cash & Short-Term Investments
26.0423.496.093.3215.4311.95
Cash Growth
373.39%285.70%83.49%-78.50%29.13%1224.40%
Other Receivables
1.40.990.650.770.770.3
Receivables
1.40.990.650.770.770.3
Prepaid Expenses
0.480.93.913.381.490.19
Other Current Assets
-----0-
Total Current Assets
27.9225.3710.657.4617.6912.44
Property, Plant & Equipment
1.241.31.07---
Long-Term Deferred Charges
1.891.891.891.891.891.89
Other Long-Term Assets
-0--0--17.05
Total Assets
31.0528.5713.69.3519.5731.37
Accounts Payable
2.781.531.232.21.670.99
Accrued Expenses
1.390.840.951.230.971.17
Other Current Liabilities
3.416.912.770.270.160.07
Total Current Liabilities
7.579.284.953.692.82.22
Other Long-Term Liabilities
-0----0-0
Total Liabilities
7.579.284.953.692.82.22
Common Stock
1.641.481.231.161.030.84
Additional Paid-In Capital
99.5589.7268.8964.8659.3952.49
Retained Earnings
-77.71-71.91-61.46-60.36-44.11-24.73
Comprehensive Income & Other
---00.470.56
Shareholders' Equity
23.4919.298.665.6616.7829.15
Total Liabilities & Equity
31.0528.5713.69.3519.5731.37
Net Cash (Debt)
26.0423.496.093.3215.4311.95
Net Cash Growth
373.39%285.70%83.49%-78.50%29.13%1224.40%
Net Cash Per Share
1.271.420.390.251.321.17
Filing Date Shares Outstanding
20.520.515.3514.4612.9111.57
Total Common Shares Outstanding
20.518.6315.3514.4612.9111.57
Working Capital
20.3616.095.73.7714.8910.21
Book Value Per Share
1.151.040.560.391.302.52
Tangible Book Value
23.4919.298.665.6616.7829.15
Tangible Book Value Per Share
1.151.040.560.391.302.52